Glaukos (GKOS) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21% |
| Dec 31, 2025 | 7.18% |
| Sep 30, 2025 | 7.59% |
| Jun 30, 2025 | 16.37% |
| Mar 31, 2025 | 1.10% |
| Dec 31, 2024 | 9.13% |
| Sep 30, 2024 | 1.02% |
| Jun 30, 2024 | 11.76% |
| Mar 31, 2024 | 3.95% |
| Dec 31, 2023 | 5.53% |
| Sep 30, 2023 | -2.92% |
| Jun 30, 2023 | 8.80% |
| Mar 31, 2023 | 3.75% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -1.95% |
| Jun 30, 2022 | 7.39% |
| Mar 31, 2022 | -7.59% |
| Dec 31, 2021 | -1.97% |
| Sep 30, 2021 | -4.33% |
| Jun 30, 2021 | 14.90% |
| Mar 31, 2021 | -7.19% |
| Dec 31, 2020 | 12.96% |
| Sep 30, 2020 | 105.43% |
| Jun 30, 2020 | -42.97% |
| Mar 31, 2020 | -15.97% |
| Dec 31, 2019 | 12.55% |
| Sep 30, 2019 | -0.16% |
| Jun 30, 2019 | 8.47% |
| Mar 31, 2019 | -0.09% |
| Dec 31, 2018 | 23.16% |
| Sep 30, 2018 | 1.73% |
| Jun 30, 2018 | 7.54% |
| Mar 31, 2018 | -3.64% |
| Dec 31, 2017 | 3.06% |
| Sep 30, 2017 | -2.11% |
| Jun 30, 2017 | 14.98% |
| Mar 31, 2017 | 8.24% |
| Dec 31, 2016 | 12.15% |
| Sep 30, 2016 | 3.58% |
| Jun 30, 2016 | 23.66% |
| Mar 31, 2016 | 13.89% |
| Dec 31, 2015 | 6.69% |
| Sep 30, 2015 | 7.04% |
| Jun 30, 2015 | 21.06% |
| Mar 31, 2015 | 3.92% |
| Dec 31, 2014 | 16.39% |
| Sep 30, 2014 | 9.25% |
| Jun 30, 2014 | 34.55% |